Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use AMPYRA safely and effectively. See full prescribing information for AMPYRA.AMPYRA ® (dalfampridine) extended-release tablets, for oral use Initial U.S. Approval: 2010
Medication labelWhy this: Advisory · dailymed-prescription
AMPYRA is indicated as a treatment to improve walking in adult patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed [see Clinical Studies (14)].
- generic_name
- dalfampridine
- product_names
- Dalfampridine
- ndc
- 0259-5010, 0259-5010-60
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en